The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life (QoL) in patients with recurrent ovarian clear cell carcinoma (rOCCC) receiving durvalumab (D) versus physician’s choice chemotherapy (PCC) in the randomized phase II MOCCA/APGOT-OV2/GCGS-OV3 trial.
 
Natalie YL Ngoi
Honoraria - AstraZeneca; Merck/Pfizer
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Eisai
 
Haoyang Sun
No Relationships to Disclose
 
Chel Hun Choi
No Relationships to Disclose
 
Valerie Heong
Honoraria - AstraZeneca; DKSH; Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; DKSH; Merck; Novartis; Pfizer
 
Samuel Guan Wei Ow
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer
 
Wen Yee Chay
No Relationships to Disclose
 
Hee Seung Kim
No Relationships to Disclose
 
Geraldine Goss
Honoraria - Merck
Consulting or Advisory Role - AstraZeneca
 
Jeffrey C. Goh
Stock and Other Ownership Interests - ICON Cancer Care; Immutep
Honoraria - Ipsen; MSD Oncology
Consulting or Advisory Role - BMS; GlaxoSmithKline; Janssen Oncology; MSD
Speakers' Bureau - AstraZeneca/MedImmune; Ipsen; Janssen; MSD Oncology; Pfizer/EMD Serono
Research Funding - BeiGene (Inst)
Travel, Accommodations, Expenses - Bayer; Pfizer/EMD Serono
 
Meiqi Lin
No Relationships to Disclose
 
Diana Lim
No Relationships to Disclose
 
Jae-Weon Kim
No Relationships to Disclose
 
Michael Friedlander
Honoraria - AstraZeneca; GlaxoSmithKline; MSD; Novartis
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; GlaxoSmithKline; Incyclix Bio; Lilly; MSD; Novartis; Takeda
Speakers' Bureau - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Novartis (Inst)
 
Bee Choo Tai
No Relationships to Disclose
 
Kidong Kim
No Relationships to Disclose
 
David Shao Peng Tan
Stock and Other Ownership Interests - Asian Microbiome Library
Honoraria - AstraZeneca; Bayer; Eisai; Foundation Medicine; Merck; MSD; Roche; Turbine
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; GlaxoSmithKline; Merck; MSD; Roche
Speakers' Bureau - Roche
Research Funding - AstraZeneca; Bayer; Karyopharm Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Merck; Novartis; Roche